Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
122670793 | 12267079 | 3 | F | 20160719 | 20160414 | 20160802 | EXP | US-PFIZER INC-2016195154 | PFIZER | 66.00 | YR | F | Y | 96.00000 | KG | 20160802 | CN | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
122670793 | 12267079 | 1 | PS | SUTENT | SUNITINIB MALATE | 1 | 50 MG, CYCLIC (4 CAPSULES DAILY 12.5MG, 28 DAYS ON/14 DAYS OFF) | Y | Z625A | 21938 | 50 | MG | CAPSULE, HARD | ||||||
122670793 | 12267079 | 2 | C | HYDROCODONE BITARTRATE AND ACETAMINOPHEN | ACETAMINOPHENHYDROCODONE BITARTRATE | 1 | UNK | 0 | |||||||||||
122670793 | 12267079 | 3 | C | METOPROLOL. | METOPROLOL | 1 | UNK | 0 | |||||||||||
122670793 | 12267079 | 4 | C | COZAAR | LOSARTAN POTASSIUM | 1 | UNK | 0 | |||||||||||
122670793 | 12267079 | 5 | C | XANAX | ALPRAZOLAM | 1 | UNK | 0 | |||||||||||
122670793 | 12267079 | 6 | C | FOLIC ACID. | FOLIC ACID | 1 | UNK | 0 | |||||||||||
122670793 | 12267079 | 7 | C | NAPROXEN. | NAPROXEN | 1 | UNK, AS NEEDED | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
122670793 | 12267079 | 1 | Renal cell carcinoma |
122670793 | 12267079 | 2 | Rheumatoid arthritis |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
122670793 | 12267079 | HO |
122670793 | 12267079 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
122670793 | 12267079 | Arthralgia | |
122670793 | 12267079 | Chapped lips | |
122670793 | 12267079 | Cyst | |
122670793 | 12267079 | Dry mouth | |
122670793 | 12267079 | Dry skin | |
122670793 | 12267079 | Dyspepsia | |
122670793 | 12267079 | Dysphagia | |
122670793 | 12267079 | Erythema | |
122670793 | 12267079 | Fatigue | |
122670793 | 12267079 | Furuncle | |
122670793 | 12267079 | Gingival discomfort | |
122670793 | 12267079 | Haemorrhage | |
122670793 | 12267079 | Hypersomnia | |
122670793 | 12267079 | Lip haemorrhage | |
122670793 | 12267079 | Oral discomfort | |
122670793 | 12267079 | Oropharyngeal pain | |
122670793 | 12267079 | Pain | |
122670793 | 12267079 | Palmar-plantar erythrodysaesthesia syndrome | |
122670793 | 12267079 | Rash | |
122670793 | 12267079 | Swelling face | |
122670793 | 12267079 | Tongue discomfort | |
122670793 | 12267079 | Weight increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
122670793 | 12267079 | 1 | 20160314 | 0 |